Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Pharmacogenomics|July 15, 2005
Small inhibitory RNA--a tool for credentialing candidate genesRichard A Walgren, Howard L McLeod
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2005
Pharmacogenomic discovery approaches: will the real genes please stand up?Richard A Walgren, Melissa A Meucci, Howard L McLeod
Advances in Hematology|January 9, 2023
Outcomes among Patients with Mantle Cell Lymphoma Post-Covalent BTK Inhibitor Therapy in the United States: A Real-World Electronic Medical Records StudyLisa M Hess, Yongmei Chen, Paolo B Abada, et al.
Plos One|March 13, 2014
Survival patterns in United States (US) medicare enrollees with non-CML myeloproliferative neoplasms (MPN)Gregory L Price, Keith L Davis, Sudeep Karve, et al.
Clinical Lymphoma, Myeloma & Leukemia|November 5, 2022
Outcomes for Patients With Chronic Lymphocytic Leukemia (CLL) Previously Treated With Both a Covalent BTK and BCL2 Inhibitor in the United States: A Real-World Database StudyAnthony R Mato, Lisa M Hess, Yongmei Chen, et al.
Journal of Cachexia, Sarcopenia and Muscle|July 28, 2018
LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trialTalia Golan, Ravit Geva, Donald Richards, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 31, 2013
Inhibition of tumor growth and metastasis in non-small cell lung cancer by LY2801653, an inhibitor of several oncokinases, including METWenjuan Wu, Chen Bi, Kelly M Credille, et al.
Investigational New Drugs|December 1, 2017
MET-targeting antibody (emibetuzumab) and kinase inhibitor (merestinib) as single agent or in combination in a cancer model bearing MET exon 14 skippingS Betty Yan, Suzane L Um, Victoria L Peek, et al.
Plos One|February 26, 2009
Integrated genomic analysis implicates haploinsufficiency of multiple chromosome 5q31.2 genes in de novo myelodysplastic syndromes pathogenesisTimothy A Graubert, Michelle A Payton, Jin Shao, et al.
Leukemia & Lymphoma|March 29, 2023
Clinical outcomes among patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) who received treatment with a covalent BTK and BCL2 inhibitor in the United States: a real-world database studyToby A Eyre, Lisa M Hess, Tomoko Sugihara, et al.
Pageof 3